Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.

Wilding, John P H et al.·Diabetes·2022·
RPEP-065922022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Published In:
Diabetes, obesity & metabolism, 24(8), 1553-1564 (2022)
Database ID:
RPEP-06592

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06592·https://rethinkpeptides.com/research/RPEP-06592

APA

Wilding, John P H; Batterham, Rachel L; Davies, Melanie; Van Gaal, Luc F; Kandler, Kristian; Konakli, Katerina; Lingvay, Ildiko; McGowan, Barbara M; Oral, Tugce Kalayci; Rosenstock, Julio; Wadden, Thomas A; Wharton, Sean; Yokote, Koutaro; Kushner, Robert F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.. Diabetes, obesity & metabolism, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725

MLA

Wilding, John P H, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.." Diabetes, 2022. https://doi.org/10.1111/dom.14725

RethinkPeptides

RethinkPeptides Research Database. "Weight regain and cardiometabolic effects after withdrawal o..." RPEP-06592. Retrieved from https://rethinkpeptides.com/research/wilding-2022-weight-regain-and-cardiometabolic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.